Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

from Biologic Therapy In Rheumatoid Arthritis · host Rheumatology News International

This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.

Episode metadata supplied by the publisher feed · Published Feb 6, 2009

Embed this episode

Attribution link and audio player

NOW PLAYING

Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy

0:00 16:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biologic Therapy In Rheumatoid Arthritis?

This episode is 16 minutes long.

When was this Biologic Therapy In Rheumatoid Arthritis episode published?

This episode was published on February 6, 2009.

Can I download this Biologic Therapy In Rheumatoid Arthritis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!